Alnylam and Regulus Therapeutics (Regulus) have reported that the US Patent and Trademark Office (USPTO) has issued a notice of allowance for the Manoharan patent (application number 11/200703),
Caraco Pharmaceutical has launched sumatriptan succinate tablets on behalf of Sun Pharmaceutical Industries, immediately following Sun Pharma’s recently received FDA approval for its Abbreviated New Drug Application (ANDA)
PCAS and Nanosyn have signed a joint-venture agreement to operate PCAS-Nanosyn, a Good Manufacturing Practice (cGMP) kilolab in Santa Rosa, Northern California. The newly created company, PCAS-Nanosyn will
Corcept Therapeutics, a pharmaceutical company engaged in the development of drugs for the treatment of severe metabolic and psychiatric disorders, has reported financial results for the second quarter
Cornerstone Therapeutics has reported an increase in net revenues by 78% to $25m for the second quarter ended June 30, 2009, as compared to $14m for the second
Hospira has reported the US Food and Drug Administration’s approval and launch of oxaliplatin injection in the US. The medication is a generic version of Sanofi-Aventis’ Eloxatin. Hospira’s
NuPathe has reported the top-line results from the pivotal phase III clinical trial of Zelrix, a novel transdermal patch in clinical development, for the treatment of acute migraine.
Teva has announced the FDA approval and launch of Oxaliplatin Injection. Teva’s 505(b)(2) New Drug Application provides for the use of Oxaliplatin Injection, 50mg/10ml and 100mg/20ml, for adjuvant
Tolerx has reported changes to the protocol for its phase 3 clinical trial – DEFEND. The trial is testing the safety and efficacy of otelixizumab, a targeted T
A 96-week study results published in AIDS (the official journal of the International AIDS Society) has shown that Prezista (darunavir) was found to be non-inferior to lopinavir/RITONAVIR. The
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.